Landfar Bio-medicine Co., Ltd (SHE:000504)
China flag China · Delayed Price · Currency is CNY
9.19
-0.30 (-3.16%)
Apr 30, 2026, 12:04 PM CST

Landfar Bio-medicine Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 2021 - 2017
Cash & Equivalents
346.77207.36493.81218.15153
Upgrade
Trading Asset Securities
-0.611.721.690.5
Upgrade
Cash & Short-Term Investments
346.77207.97495.53219.83153.51
Upgrade
Cash Growth
66.74%-58.03%125.41%43.21%126.76%
Upgrade
Accounts Receivable
320.48139.58123.22158.76197.92
Upgrade
Other Receivables
18.0213.6219.3527.678.82
Upgrade
Receivables
338.5153.2142.57186.43206.74
Upgrade
Inventory
18.6734.0610.664.510.64
Upgrade
Prepaid Expenses
-0.160.070.030.57
Upgrade
Other Current Assets
34.996.516.025.44145.17
Upgrade
Total Current Assets
738.92401.9654.85416.24516.62
Upgrade
Property, Plant & Equipment
170.2226.0528.0635.9335.85
Upgrade
Long-Term Investments
-1005.425.485.98
Upgrade
Goodwill
6.231.981.988.448.44
Upgrade
Other Intangible Assets
55.811.860.440.360.22
Upgrade
Long-Term Accounts Receivable
-0.030.040.060.07
Upgrade
Long-Term Deferred Tax Assets
8.711.921.110.61.05
Upgrade
Long-Term Deferred Charges
10.8373.7579.4885.6789.58
Upgrade
Other Long-Term Assets
1.010.67-0.581.44
Upgrade
Total Assets
991.73608.17771.38553.37659.25
Upgrade
Accounts Payable
14.7284.4782.2182.0389.56
Upgrade
Accrued Expenses
7.748.039.018.616.17
Upgrade
Short-Term Debt
270.25-187.71218.73293.06
Upgrade
Current Portion of Long-Term Debt
14.81---
Upgrade
Current Portion of Leases
-3.613.162.812.35
Upgrade
Current Income Taxes Payable
15.362.581.627.194.88
Upgrade
Current Unearned Revenue
201.45185.18151.41119.74123.84
Upgrade
Other Current Liabilities
20.8420.6117.2816.049.14
Upgrade
Total Current Liabilities
545.16305.47452.4455.15529
Upgrade
Long-Term Debt
52.959---
Upgrade
Long-Term Leases
3.2410.451314.7916.89
Upgrade
Long-Term Unearned Revenue
26.641.11.061.831.4
Upgrade
Long-Term Deferred Tax Liabilities
6.240.150.250.410.64
Upgrade
Other Long-Term Liabilities
---11
Upgrade
Total Liabilities
634.22326.17466.71473.18548.93
Upgrade
Common Stock
330.02330.02330.02311.57311.57
Upgrade
Additional Paid-In Capital
423.3423.47423.47170.82160.99
Upgrade
Retained Earnings
-487.57-516.4-496.55-468.38-455.92
Upgrade
Total Common Equity
265.75237.1256.9414.0116.64
Upgrade
Minority Interest
91.7644.947.7366.1893.68
Upgrade
Shareholders' Equity
357.51282304.6780.19110.32
Upgrade
Total Liabilities & Equity
991.73608.17771.38553.37659.25
Upgrade
Total Debt
341.2424.06203.87236.33312.29
Upgrade
Net Cash (Debt)
5.53183.91291.66-16.5-158.79
Upgrade
Net Cash Growth
-97.00%-36.94%---
Upgrade
Net Cash Per Share
0.020.560.93-0.05-0.50
Upgrade
Filing Date Shares Outstanding
294.04330.02330.02311.57311.57
Upgrade
Total Common Shares Outstanding
294.04330.02330.02311.57311.57
Upgrade
Working Capital
193.7696.43202.45-38.92-12.38
Upgrade
Book Value Per Share
0.900.720.780.040.05
Upgrade
Tangible Book Value
203.71233.25254.525.217.98
Upgrade
Tangible Book Value Per Share
0.690.710.770.020.03
Upgrade
Buildings
---12.9412.94
Upgrade
Machinery
-25.0923.422.3916.85
Upgrade
Construction In Progress
----1.29
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.